DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: Amgen

News

Amgen Builds Biologics Facility in North Carolina

13.08.2021 -

US biotech Amgen is planning to spend $550 million on building a new biologics manufacturing plant in Holly Springs, Wake County in North Carolina. Construction is...

News

Amgen Boosts Antibody Portfolio with Teneobio Buy

02.08.2021 -

US biopharma Amgen has agreed to buy privately held clinical-stage biotech Teneobio in a deal worth up to $2.5 billion. The acquisition will expand Amgen’s antibody...

News

Amgen Boosts Oncology Portfolio with Five Prime Buy

10.03.2021 -

Amgen is to buy Five Prime Therapeutics, a clinical-stage biotech focused on developing immuno-oncology and targeted cancer therapies, for about $1.9 billion. The...

News

Amgen and China’s BeiGene in Oncology Partnership

04.11.2019 - US biotech Amgen has agreed to take a 20.5% stake in China’s BeiGene as the two companies enter into a strategic collaboration to develop cancer drugs. The move significantly...

News

Amgen Makes $13 billion Grab for Otezla

27.08.2019 - Contrary to recent speculation that Amgen was preparing to buy Alexion, the California-based US biotech has announced that it instead will acquire Celgene’s Otezla, the only oral...

News

Amgen Wins Enbrel Patent Case

19.08.2019 - The US District Court for the District of New Jersey has upheld two of Amgen’s patents for its top-selling drug Enbrel (etanercept) in a ruling against Sandoz, which has been...

News

Advocacy Group Sues FDA Over Dopamine Warnings

10.05.2019 - The US market watchdog Public Citizen has sued the Food and Drug Administration (FDA), demanding that a district court in Washington, DC, require the agency to add “black box”...

News

Novartis and Amgen in Migraine Dispute

17.04.2019 - Swiss drugmaker Novartis and US biopharma Amgen are embroiled in a legal dispute regarding their collaboration on migraine prevention drug Aimovig. Novartis has filed a complaint...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.

Social Media

LinkedIn | Twitter

Subscribe to our Newsletter!

Newsletter

We keep you posted - Subscribe to the CHEManager International newsletter here!

Social Media

LinkedIn | Twitter

Subscribe to our Newsletter!

Newsletter

We keep you posted - Subscribe to the CHEManager International newsletter here!